Patents by Inventor Dorothea Erxleben

Dorothea Erxleben has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Long-acting non-aqueous injectable formulations and use thereof
    Patent number: 11058629
    Abstract: Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for subcutaneous injection, in particular analgesics such as buprenorphine.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: July 13, 2021
    Assignee: Piedmont Animal Health Inc.
    Inventors: Douglas I. Hepler, Gail L. Dempsey, Dorothea Erxleben
  • OTIC FORMULATIONS, METHODS AND DEVICES
    Publication number: 20210106597
    Abstract: The present invention relates to a formulation and method for treating an ear infection, especially otomycosis and otitis externa, by administering a one-time only treatment comprising an antibiotic, antifungal, and an anti-inflammatory in a thick, otic carrier. In one embodiment, the formulation comprises a therapeutically effective amount of active ingredients including a marbofloxacin, terbinafine and/or clotrimazole and dexamethasone.
    Type: Application
    Filed: October 8, 2020
    Publication date: April 15, 2021
    Inventors: Douglas I. Hepler, Gail L. Dempsey, Dorothea A. Erxleben, Neil E. Paulsen
  • LONG-ACTING INJECTABLE FORMULATIONS AND USE THEREOF
    Publication number: 20200368263
    Abstract: Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for subcutaneous injection.
    Type: Application
    Filed: May 20, 2020
    Publication date: November 26, 2020
    Inventors: Gail L. Dempsey, Douglas L. Hepler, Dorothea Erxleben, Michael S. Daniel, Neil E. Paulsen
  • LONG-ACTING NON-AQUEOUS INJECTABLE FORMULATIONS AND USE THEREOF
    Publication number: 20200237653
    Abstract: Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for subcutaneous injection, in particular analgesics such as buprenorphine.
    Type: Application
    Filed: January 31, 2020
    Publication date: July 30, 2020
    Inventors: Douglas I. Hepler, Gail L. Dempsey, Dorothea Erxleben
  • Long-acting non-aqueous injectable formulations and use thereof
    Patent number: 10555899
    Abstract: Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for subcutaneous injection, in particular analgesics such as buprenorphine.
    Type: Grant
    Filed: June 5, 2018
    Date of Patent: February 11, 2020
    Assignee: Piedmont Animal Health, LLC
    Inventors: Douglas I. Hepler, Gail L. Dempsey, Dorothea Erxleben
  • LONG-ACTING NON-AQUEOUS INJECTABLE FORMULATIONS AND USE THEREOF
    Publication number: 20180344629
    Abstract: Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for subcutaneous injection, in particular analgesics such as buprenorphine.
    Type: Application
    Filed: June 5, 2018
    Publication date: December 6, 2018
    Inventors: Douglas I. Hepler, Gail L. Dempsey, Dorothea Erxleben